Bioequivalence Testing Services for Abbreviated New Drug Application

At Next Breath, We have a proven track record of working with regulatory agencies to ensure a higher product approval rate. Finding a devoted analytical services partner can often be an arduous task of trial and error, and in an environment where “getting it right the first time” for ANDA Submission counts, choosing the right one is critical. This download provides Bioequivalence Testing Services for Abbreviated New Drug Application.